China’s BVCF Targets $400 Million For Fourth Fund

This Data Is Locked!

This area is available only to Subscribers.

BVCF (BioVeda China Fund), a Shanghai-based private equity and venture investment firm focused on life sciences, is targeting US$400 million for its fourth U.S. dollar... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?